Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Warfarin--indications, risks and drug interactions Tadros R; Shakib SAust Fam Physician 2010[Jul]; 39 (7): 476-9BACKGROUND: Warfarin is a commonly used medication for the prevention and treatment of venous thromboembolism. It can be challenging for both the patient and the prescriber to manage at times. OBJECTIVE: To describe the mechanism of action of warfarin, and to discuss the indications for warfarinisation, the risks associated with warfarin use, and some of its drug interactions. DISCUSSION: The common indications for warfarinisation are atrial fibrillation, venous thromboembolism and prosthetic heart valves. Contraindications include absolute and relative contraindications, and an individualised risk-benefit analyses is required for each patient. There are many interactions with warfarin, including pharmacokinetic and pharmacodynamic. Pharmacokinetic interactions can be monitored by using International Normalised Ratio levels. Pharmacodynamic interactions require knowledge by the prescriber to predict any interactions with warfarin, and International Normalised Ratio monitoring assists.|Anticoagulants/adverse effects/pharmacology/*therapeutic use[MESH]|Atrial Fibrillation/*drug therapy/etiology[MESH]|Cytochrome P-450 Enzyme System[MESH]|Drug Interactions[MESH]|Heart Valve Prosthesis/adverse effects[MESH]|Humans[MESH]|International Normalized Ratio[MESH]|Risk Factors[MESH]|Venous Thromboembolism/complications/*drug therapy[MESH]|Vitamin K/analysis/antagonists & inhibitors[MESH]|Warfarin/adverse effects/pharmacology/*therapeutic use[MESH] |